# Fortress Biotech, Inc.: filings

FBIO · Nasdaq · CIK 1429260 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fbio.md) · [Financials](/companies/fbio/financials.md) · [Filings](/companies/fbio/filings.md) · [Insiders](/companies/fbio/insiders.md)

## Reports and events: 358 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 251, 8-K 221, 10-Q 45, 3 33, SC 13D/A 27, 424B5 22, EFFECT 22, CORRESP 21, SC 13G/A 19, DEF 14A 18, DEFA14A 18, UPLOAD 18, 10-K 15, 424B3 13, SC 13G 13, S-3 11, S-8 11, SCHEDULE 13D/A 11, D 9, POS AM 9, FWP 8, PRE 14A 8, S-3/A 8, SC 13D 7, 4/A 5, CT ORDER 5, S-1 4, S-1/A 4, 10-12G/A 3, 10-K/A 3, 8-A12B 2, 8-K/A 2, CERTNAS 2, PX14A6G 2, SC TO-C 2, SC TO-T/A 2, 10-12G 1, 10-Q/A 1, 144 1, 424B4 1, 424B7 1, D/A 1, S-1MEF 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 16:30 ET | [8-K](/filings/0001104659-26-112845.md) | 8.01 Other events | 0001104659-26-112845 |
| 2026-08-13 | 16:31 ET | [10-Q](/filings/0001104659-26-095964.md) | Quarterly report, period 2026-06-30 | 0001104659-26-095964 |
| 2026-08-13 | 16:15 ET | [8-K](/filings/0001104659-26-095931.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095931 |
| 2026-06-23 | 16:05 ET | [8-K](/filings/0001104659-26-076811.md) | 5.07 Shareholder vote results | 0001104659-26-076811 |
| 2026-05-14 | 16:31 ET | [10-Q](/filings/0001104659-26-061233.md) | Quarterly report, period 2026-03-31 | 0001104659-26-061233 |
| 2026-05-14 | 16:23 ET | [8-K](/filings/0001104659-26-061208.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-061208 |
| 2026-04-28 | 16:15 ET | [DEF 14A](/filings/0001104659-26-050358.md) | Proxy statement, period 2026-06-17 | 0001104659-26-050358 |
| 2026-03-31 | 17:05 ET | [10-K](/filings/0001104659-26-037874.md) | Annual report, period 2025-12-31 | 0001104659-26-037874 |
| 2026-03-31 | 16:15 ET | [8-K](/filings/0001104659-26-037749.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-037749 |
| 2026-03-30 | 17:30 ET | [8-K](/filings/0001104659-26-036818.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-036818 |
| 2026-03-20 | 16:16 ET | [SCHEDULE 13D/A](/filings/0001104659-26-032728.md) | Ownership report, active investor, amended | 0001104659-26-032728 |
| 2026-02-23 | 08:35 ET | [8-K](/filings/0001104659-26-018371.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-018371 |
| 2026-01-13 | 09:19 ET | [8-K](/filings/0001104659-26-003121.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-003121 |
| 2026-01-06 | 16:11 ET | [SCHEDULE 13D/A](/filings/0001104659-26-001305.md) | Ownership report, active investor, amended | 0001104659-26-001305 |
| 2026-01-05 | 17:00 ET | [SCHEDULE 13D/A](/filings/0001104659-26-000690.md) | Ownership report, active investor, amended | 0001104659-26-000690 |
| 2025-12-16 | 17:53 ET | [S-1](/filings/0001104659-25-121266.md) | Registration statement | 0001104659-25-121266 |
| 2025-12-15 | 16:33 ET | [8-K](/filings/0001104659-25-121187.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001104659-25-121187 |
| 2025-12-15 | 08:30 ET | [8-K](/filings/0001104659-25-120893.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120893 |
| 2025-11-17 | 07:30 ET | [8-K](/filings/0001104659-25-112945.md) | 8.01 Other events | 0001104659-25-112945 |
| 2025-11-14 | 08:46 ET | [10-Q](/filings/0001104659-25-111989.md) | Quarterly report, period 2025-09-30 | 0001104659-25-111989 |
| 2025-11-14 | 08:35 ET | [8-K](/filings/0001104659-25-111979.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-111979 |
| 2025-10-01 | 16:11 ET | [SCHEDULE 13D/A](/filings/0001104659-25-095631.md) | Ownership report, active investor, amended | 0001104659-25-095631 |
| 2025-10-01 | 08:45 ET | [8-K](/filings/0001104659-25-095366.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-095366 |
| 2025-08-14 | 16:16 ET | [10-Q](/filings/0001558370-25-011570.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011570 |
| 2025-08-14 | 16:10 ET | [8-K](/filings/0001558370-25-011561.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011561 |
| 2025-07-16 | 17:25 ET | [8-K](/filings/0001558370-25-009264.md) | 8.01 Other events | 0001558370-25-009264 |
| 2025-06-23 | 08:55 ET | [8-K](/filings/0001558370-25-008787.md) | 5.07 Shareholder vote results | 0001558370-25-008787 |
| 2025-06-05 | 16:15 ET | [8-K](/filings/0001558370-25-008433.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001558370-25-008433 |
| 2025-06-03 | 18:46 ET | [SCHEDULE 13D/A](/filings/0001104659-25-056072.md) | Ownership report, active investor, amended | 0001104659-25-056072 |
| 2025-05-15 | 16:34 ET | [10-Q](/filings/0001558370-25-007898.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007898 |
| 2025-05-15 | 16:10 ET | [8-K](/filings/0001558370-25-007878.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007878 |
| 2025-04-28 | 16:05 ET | [DEF 14A](/filings/0001558370-25-005678.md) | Proxy statement, period 2025-06-17 | 0001558370-25-005678 |
| 2025-04-16 | 16:15 ET | [8-K](/filings/0001558370-25-004898.md) | 5.02 Departure or appointment of officers or directors | 0001558370-25-004898 |
| 2025-04-02 | 17:16 ET | [SCHEDULE 13D/A](/filings/0001104659-25-031261.md) | Ownership report, active investor, amended | 0001104659-25-031261 |
| 2025-04-02 | 17:00 ET | [SCHEDULE 13D/A](/filings/0001104659-25-031241.md) | Ownership report, active investor, amended | 0001104659-25-031241 |
| 2025-03-31 | 16:15 ET | [10-K](/filings/0001558370-25-004160.md) | Annual report, period 2024-12-31 | 0001558370-25-004160 |
| 2025-03-31 | 16:10 ET | [8-K](/filings/0001558370-25-004154.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-004154 |
| 2025-03-11 | 16:29 ET | [SCHEDULE 13D/A](/filings/0001104659-25-022575.md) | Ownership report, active investor, amended | 0001104659-25-022575 |
| 2025-03-10 | 08:30 ET | [8-K](/filings/0001558370-25-002541.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-25-002541 |
| 2025-01-16 | 16:20 ET | [8-K](/filings/0001558370-25-000247.md) | 8.01 Other events | 0001558370-25-000247 |
| 2025-01-06 | 08:05 ET | [8-K](/filings/0001558370-25-000025.md) | 8.01 Other events | 0001558370-25-000025 |
| 2025-01-03 | 18:26 ET | [SCHEDULE 13D/A](/filings/0001104659-25-000921.md) | Ownership report, active investor, amended | 0001104659-25-000921 |
| 2025-01-03 | 18:26 ET | [SCHEDULE 13D/A](/filings/0001104659-25-000920.md) | Ownership report, active investor, amended | 0001104659-25-000920 |
| 2025-01-03 | 17:50 ET | [SCHEDULE 13D/A](/filings/0001104659-25-000898.md) | Ownership report, active investor, amended | 0001104659-25-000898 |
| 2024-12-16 | 16:50 ET | [8-K](/filings/0001558370-24-016294.md) | 8.01 Other events | 0001558370-24-016294 |
| 2024-11-15 | 16:05 ET | [SC 13D/A](/filings/0001104659-24-119704.md) | Ownership report, active investor, amended | 0001104659-24-119704 |
| 2024-11-14 | 16:40 ET | [10-Q](/filings/0001558370-24-015740.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015740 |
| 2024-11-14 | 16:24 ET | [8-K](/filings/0001558370-24-015726.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015726 |
| 2024-11-04 | 09:11 ET | [8-K](/filings/0001558370-24-014186.md) | 8.01 Other events | 0001558370-24-014186 |
| 2024-10-01 | 16:15 ET | [SC 13D/A](/filings/0001104659-24-104932.md) | Ownership report, active investor, amended | 0001104659-24-104932 |

Page 1 of 8. [Older](/companies/fbio/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:38 ET. No prices; not investment advice.